Sociodemographic and clinical profile of patients attending a post-COVID-19 rehabilitation program: a multicenter cross-sectional study
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20250388Keywords:
Long COVID-19, Neurological manifestations, Post COVID-19 rehabilitationAbstract
Background: Neurological and musculoskeletal manifestations related to COVID-19 are prevalent and can persist beyond 12 weeks, characterizing the “Long COVID”. This paper aims to describe the sociodemographic and clinical profile reporting the prevalence of cognitive, emotional and motor symptoms of patients seen at 2 Brazilian-Rehabilitation hospitals.
Methods: Multicentric, descriptive and observational, cross-sectional study, carried out by reviewing the electronic medical records of patients, from March to September 2021.
Results: 611 individuals participated in the study (mean age: 53.4 years), 58.4% were female. Three or more pre-existing comorbidities were reported by 38.6%. Three or more persistent symptoms were present in 77.3%. Neuropsychiatric (65.0%) and memory/attention impairments (55.6%); pain (53.7%) and fatigue (51.6%) were the most prevalent. The majority had the post COVID-19 functional status scale (PCSF) score to ≥2 (66.9%). There was no association between infection severity and reported functional status. Most of the participants did not show risk of fall at Timed Up and Go Test (TUG) (68.6%), and 93.9% presented an average walking speed of ≥ 0.80 m/s. Analyzing the COVID-19 severity and TUG test results, it was identified that severely or critical affected patients had moderate to high risk of fall (P=0,02). There were associations between functional status and gait speed (P=0,01) as well as with the presence of fatigue as a persistent symptom (p=0,03).
Conclusions: The study contributes to the knowledge of sociodemographic and clinical profile of patients who had COVID-19, showing persistent symptoms and the impact of Long-COVID on the individual's function.
Metrics
References
Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J of Neurol. 2020;267:2179-84. DOI: https://doi.org/10.1007/s00415-020-09929-7
Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018-27. DOI: https://doi.org/10.1001/jamaneurol.2020.2065
Hassett CE, Gedansky A, Migdady I, Bhimraj A, Uchino K, Cho SM. Neurologic complications of COVID-19. Cleveland Clin J of Med. 2020;87(12):729-34. DOI: https://doi.org/10.3949/ccjm.87a.ccc058
Li H, Xue Q, Xu X. Involvement of the nervous system in SARS-CoV-2 infection. Neurotox Res. 2020;38:1-7. DOI: https://doi.org/10.1007/s12640-020-00219-8
Nath A. Neurologic manifestations of severe acute respiratory syndrome coronavirus 2 infection. CONTINUUM Lifelong Learning in Neurol. 2021;27(4):1051-65. DOI: https://doi.org/10.1212/CON.0000000000000992
Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-5. DOI: https://doi.org/10.1001/jama.2020.12603
Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical Microbiol and Infec. 2021;27(2):258-63. DOI: https://doi.org/10.1016/j.cmi.2020.09.052
Colucci E, Nadeau S, Higgins J, Kehayia E, Poldma T, Saj A, et al. COVID-19 lockdowns’ effects on the quality of life, perceived health and well-being of healthy elderly individuals: A longitudinal comparison of pre-lockdown and lockdown states of well-being. Arch Gerontol Geriat. 2022;99:104606. DOI: https://doi.org/10.1016/j.archger.2021.104606
Indrawati L, Tjandrarini DH, Sulistiyowati N, Afifah T, Paramita A, Senewe FP, Dewantara PW. Characteristics of hospitalized patients with confirmed COVID-19 and their hospital management. Asian Pacific J of Trop Med. 2024;17(3):129-35. DOI: https://doi.org/10.4103/apjtm.apjtm_520_23
Bilkhair A. Clinical management of COVID-19: Living guideline. Geneva: World Health Organization. 2022;4:56.
Klok FA, Boon GJ, Barco S, Endres M, Geelhoed JM, Knauss S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. European Resp J. 2020;56(1):89. DOI: https://doi.org/10.1183/13993003.01494-2020
Rodrigues RA, Teodózio MM, Espinosa MM, Fett WC, Melo CD, Fett CA. Timed up and go test and self-perceived health in elderly: population-based study. Revista Brasileira de Cineantropometria & Desempenho Humano. 2018;20:247-57. DOI: https://doi.org/10.5007/1980-0037.2018v20n3p247
Bowden MG, Balasubramanian CK, Behrman AL, Kautz SA. Validation of a speed-based classification system using quantitative measures of walking performance poststroke. Neurorehabilitation and neural repair. 2008;22(6):672-5. DOI: https://doi.org/10.1177/1545968308318837
Siahaan YM, Hartoyo V, Hariyanto TI, Kurniawan A. Coronavirus disease 2019 (Covid-19) outcomes in patients with sarcopenia: a meta-analysis and meta-regression. Clinical nutrition ESPEN. 2022;48:158-66. DOI: https://doi.org/10.1016/j.clnesp.2022.01.016
Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet. 2022;22(4):102-7. DOI: https://doi.org/10.1016/S1473-3099(21)00703-9
Nascimento JMR do, Naves MA, Rosa IBP. Functional impact of post-COVID-19: persistent COVID. Rev Sau Aer 2020;5(1):21–7.
Braga LW, Oliveira SB, Moreira AS, Pereira ME, Carneiro VS, Serio AS, et al. Neuropsychological manifestations of long COVID in hospitalized and non-hospitalized Brazilian Patients. Neuro Rehabilitation. 2022;50(4):391-400. DOI: https://doi.org/10.3233/NRE-228020
Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. Am Med Association (AMA); 2022;328:1604.
Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Vol. 28, Nature Medicine. Springer Science and Business Media LLC; 2022: 1706–1714. DOI: https://doi.org/10.1038/s41591-022-01909-w
Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Euro J Internal Med. Elsevier BV; 2021:92:55–70. DOI: https://doi.org/10.1016/j.ejim.2021.06.009
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol Am Med Association (AMA); 2020;77:683. DOI: https://doi.org/10.1001/jamaneurol.2020.1127
Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?. Vol. 6, ERJ Open Research. European Respiratory Society (ERS); 2020;6:00542–2020. DOI: https://doi.org/10.1183/23120541.00542-2020
Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Vol. 27, Clinical Microbiology and Infection. Elsevier BV; 2021. p. 89–95. Available from: http://dx.doi.org/10.1016/j.cmi.2020.09.023 DOI: https://doi.org/10.1016/j.cmi.2020.09.023
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Cold Spring Harbor Laboratory; 2021. DOI: https://doi.org/10.21203/rs.3.rs-266574/v1
Wong AW, Shah AS, Johnston JC, Carlsten C, Ryerson CJ. Patient-reported outcome measures after COVID-19: a prospective cohort study. Euro Respiratory J. European Respiratory Society (ERS); 2020;56: 2003276. DOI: https://doi.org/10.1183/13993003.03276-2020
Morin L, Savale L, Pham T, Colle R, Figueiredo S. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. Vol. 325, JAMA. American Medical Association (AMA); 2021;325:1525. DOI: https://doi.org/10.1001/jama.2021.3331
Dias EBT, Teixeira ACS, Carneiro LL, Santos IM, Silva Júnior AFR, Margotto SS. Consequências neuropsiquiátricas pós infecção por SARS-CoV-2. Research, Society Development; 2022;11:e477111033244. DOI: https://doi.org/10.33448/rsd-v11i10.33244
Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. Elsevier BV; 2021;8: 416–27. DOI: https://doi.org/10.1016/S2215-0366(21)00084-5
Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurological Sci. Elsevier BV; 2022;434:120162. DOI: https://doi.org/10.1016/j.jns.2022.120162
Guzik A, Wolan-Nieroda A, Kochman M, Perenc L, Drużbicki M. Impact of mild COVID-19 on balance function in young adults, a prospective observational study. Vol. 12, Scientific Reports. Springer Science and Business Media LLC; 2022:12. DOI: https://doi.org/10.1038/s41598-022-16397-8
Machado FVC, Meys R, Delbressine JM, Vaes AW, Goërtz YMJ, van Herck M, et al. Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19. Vol. 19, Health and Quality of Life Outcomes. Springer Science and Business Media LLC; 2021;19. DOI: https://doi.org/10.1186/s12955-021-01691-2
Menezes AS, Botelho SM, Santos LR, Rezende AL. Acute COVID-19 Syndrome Predicts Severe Long COVID-19: An Observational Study. Cureus. Springer Science and Business Media LLC; 2022. DOI: https://doi.org/10.7759/cureus.29826
Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. E Clin Med. 2022;51:45. DOI: https://doi.org/10.1016/j.eclinm.2022.101549
Montes-Ibarra M, Oliveira CL, Orsso CE, Landi F, Marzetti E, Prado CM. The impact of long COVID-19 on muscle health. Clinics in Geriat Med. 2022;38(3):545-57. DOI: https://doi.org/10.1016/j.cger.2022.03.004
Frontera JA, Yang D, Lewis A, Patel P, Medicherla C, Arena V, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J of the Neurolog Sci. 2021;426:117486. DOI: https://doi.org/10.1016/j.jns.2021.117486
Hodgson CL, Higgins AM, Bailey MJ, Mather AM, Beach L, Bellomo R, et al. The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study. Critical Care. 202;25:1-2.
O’Mahony L, Buwalda T, Blair M, Forde B, Lunjani N, Ambikan A, et al. Impact of Long COVID on health and quality of life. HRB open research. 2022;5:31. DOI: https://doi.org/10.12688/hrbopenres.13516.1
Ferrarello F, Iacopino C, Pierinelli C, Paci M. Physical functioning and health-related quality of life after COVID-19: a long-term perspective case series. Int J Rehab Res. 2023;46(1):77-85. DOI: https://doi.org/10.1097/MRR.0000000000000563
de Oliveira Almeida K, Nogueira Alves IG, de Queiroz RS, de Castro MR, Gomes VA, Santos Fontoura FC, et al. A systematic review on physical function, activities of daily living and health-related quality of life in COVID-19 survivors. Chronic Illness. 2023;19(2):279-303. DOI: https://doi.org/10.1177/17423953221089309
Qurat-ul-Ain, Malik AN, Amjad I. Effect of circuit gait training vs traditional gait training on mobility performance in stroke. J Pak Med Assoc. 2018;68(3):455-8.